We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




High Blood Glucose Levels Linked to Dementia

By LabMedica International staff writers
Posted on 22 Aug 2013
Print article
Image: Quo-Lab glycated hemoglobin analyzer (Photo courtesy of EKF diagnostics).
Image: Quo-Lab glycated hemoglobin analyzer (Photo courtesy of EKF diagnostics).
Adults with a high blood sugar level may have an increased risk of developing dementia compared with those who have a normal blood sugar level.

With the aging of the population, dementia has become a major threat to public health worldwide, while the rate of obesity is also increasing, with a parallel increase in the rate of diabetes.

Scientists at the University of Washington School of Medicine (Seattle, WA, USA) analyzed various variables of 2,067 participants without dementia aged 65 and over. In order to examine the relationship between glucose levels and the risk of dementia, they analyzed the median measurements of glycated hemoglobin levels (HbA1C) and glucose levels over a period of 6.8 years.

The results of the study revealed that in the participants with diabetes, the risk of dementia was 40% higher for those with an average glucose level of 190 mg/dL, compared with participants who had an average glucose level of 160 mg/dL. The results also showed that in the participants without diabetes, the risk of dementia was 18% higher for those with an average glucose level of 115 mg/dL versus those with an average of 100 mg/dL.

The investigators said that including both glucose levels and glycated hemoglobin in the measurements was the key as blood sugar levels rise and fall throughout the day, but glycated hemoglobin does not vary as much over short periods. However, they add that these results do not necessarily mean that people should eat foods with a lower "glycemic index," but exercise may help.

Paul K. Crane, MD, MPH, an associate professor and lead author, said, “The most interesting finding was that every incrementally higher glucose level was associated with a higher risk of dementia in people who did not have diabetes. There was no threshold value for lower glucose values where risk leveled off. Your body turns your food into glucose, so your blood sugar levels depend not only on what you eat but also on your individual metabolism: how your body handles your food."

The authors concluded that although their results show that higher glucose levels are linked to higher dementia risk, there is no data to suggest people who make changes to lower their glucose levels will reduce the risk of dementia. The study was published on August 8, 2013, in the New England Journal of Medicine (NEJM).

Related Links:

University of Washington School of Medicine


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
DNA Extraction Kit
Ron’s Gel Extraction Mini Kit
New
Crypto + Giardia One Step Combo Card Test
CerTest Crypto + Giardia

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.